Anika Therapeutics, Inc. Business Combination, Contingent Consideration, Liability, Current
Anika Therapeutics, Inc. (ANIK) had Business Combination, Contingent Consideration, Liability, Current of $0 as of 2022-12-31, per its 10-K filed 2023-03-16.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2023-03-16
- 2022-12-31: Business Combination, Contingent Consideration, Liability, Current $0.00.
- 2022-09-30: Business Combination, Contingent Consideration, Liability, Current $0.00.
- 2022-06-30: Business Combination, Contingent Consideration, Liability, Current $4.32M.
- 2022-03-31: Business Combination, Contingent Consideration, Liability, Current $4.32M.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2022-12-31 | $0.00 10-K · filed 2023-03-16 |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-09 |
| 2022-06-30 | $4.32M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $4.32M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $4.32M 10-K · filed 2023-03-16 |
| 2021-09-30 | $3.49M 10-Q · filed 2021-11-05 |
| 2021-06-30 | $16.87M 10-Q · filed 2021-08-06 |
| 2021-03-31 | $24.83M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $13.09M 10-K · filed 2022-03-11 |
| 2020-09-30 | $11.86M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $11.69M 10-Q · filed 2020-08-07 |
| 2020-03-31 | $4.30M 10-Q · filed 2020-05-22 |
| 2019-12-31 | $0.00 10-K/A · filed 2021-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |